BioMarin Pharmaceutical (BMRN) Valuation Check After This Year's 20% Share Price Pullback [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
With revenue and net income still growing, the pullback raises a simple question: is this weakness justified? See our latest analysis for BioMarin Pharmaceutical. That slide reflects a broader loss of confidence, with the share price down about 20% year to date and the three year total shareholder return dragging more than 50%. At the same time, solid revenue and net income growth hint that sentiment rather than fundamentals may be driving the weaker momentum. If BioMarin's rare disease focus has you rethinking your healthcare exposure, it could be a good time to scan other opportunities across healthcare stocks and compare how they stack up. With BioMarin trading well below analyst targets despite healthy growth, investors are left weighing whether the market is overlooking its rare disease pipeline or correctly discounting future execution. Is there a real buying opportunity here, or is growth already priced in? With BioMarin last closing at $52.99 versus a narrative fair
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- Can BioMarin (BMRN) Turn Margin Ambitions Into Strength Amid Rising Rare-Disease Competition? [Yahoo! Finance]Yahoo! Finance
- Is The Market Mispricing BioMarin After Its Multi Year Share Price Slump In 2025 [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical Inc. (BMRN) Outlook Lowered By Leerink [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical (NASDAQ:BMRN) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $60.00 price target on the stock, down previously from $82.00.MarketBeat
BMRN
Earnings
- 10/27/25 - Miss
BMRN
Sec Filings
- 12/2/25 - Form 4
- 11/14/25 - Form SCHEDULE
- 10/28/25 - Form 10-Q
- BMRN's page on the SEC website